Global Pamoic Acid Market Strategic Research Report

Scope of the Report

The global Pamoic Acid market size is predicted to grow from US$ 265 million in 2025 to US$ 465 million in 2032; it is expected to grow at a CAGR of 8.5% from 2026 to 2032.

Pamoic acid, chemically known as 4,4′-methylenebis(3-hydroxy-2-naphthoic acid), is a dihydroxynaphthalene dicarboxylic acid compound with the molecular formula C₂₃H₁₆O₆. It typically exists as a yellow to orange-yellow crystalline powder. Pamoic acid itself is pharmacologically inactive, but due to its strong hydrophobicity and large molecular weight, it is often used as an anionic ligand or acidic component in pharmaceutical formulations, forming salts with various basic drugs (such as chlorpheniramine pamoate, hydroxyzine pamoate, and pyridoxine pamoate), thereby improving the drug's physicochemical and pharmacokinetic properties. Drugs that form salts with pamoic acid often exhibit lower water solubility, slower release rates, and longer durations of action, making them suitable for long-acting or sustained-release formulations. Pamoic acid can also improve drug stability, reduce gastrointestinal irritation, and regulate drug absorption rates in the body. Due to its excellent salt-forming properties and sustained-release characteristics, pamoic acid is widely used in the pharmaceutical industry in the development of formulations such as antihistamines, sedatives, antiparasitics, and nutritional supplements.

Pamoic acid's downstream applications are primarily concentrated in pharmaceutical preparations, chemical pharmaceuticals, and some fine chemicals. Its core application is as a salt-forming acid for the preparation of pamoxate salts of various drugs, thereby improving their solubility, stability, and release characteristics. In the pharmaceutical industry, pamoxate is widely used to form sparingly soluble salts with alkaline-active drugs, such as antihistamines (chlorpheniramine pamoxate and promethazine pamoxate), sedatives and hypnotics (hydroxyzine pamoxate), anthelmintics (praziquantel pamoxate), and vitamin and mineral combination preparations (pyridoxine pamoxate). These pamoxate salts typically exhibit sustained-release or long-acting properties, which can prolong the duration of drug effect, reduce dosing frequency, and improve patient compliance. Consequently, they are used in oral sustained-release tablets, injections, topical preparations, and nutritional supplements. Furthermore, with the advancement of drug delivery systems and controlled-release technologies, pamoic acid is being studied for use in novel drug delivery systems (such as microspheres, nanoparticles, and liposomes) to regulate drug release rate and targeted distribution. In addition to pharmaceutical applications, pamoic acid also has limited applications in certain fine chemicals and laboratory reagents, such as as a standard analytical reagent or organic synthesis intermediate. Overall, the downstream industry chain for pamoic acid is centered around pharmaceutical preparations. With the expansion of the global market for long-acting formulations and sustained-release drugs, its demand and application scope are steadily increasing.

In 2024, global pamoic acid production reached 3,024 tons, with an average selling price of US$83 per kilogram. Pamoic acid production capacity is 300 tons per year, with a gross profit margin of approximately 58%.

Pamoic acid plays a key role in the pharmaceutical field, especially in the development of long-acting drugs and sustained-release preparations. Its unique chemical properties enable it to form sparingly soluble salts with active pharmaceutical ingredients, thereby improving drug stability and controlling the release rate, which is essential for improving patient compliance and therapeutic efficacy. As the demand for efficient drug delivery systems grows, the application potential of pamoic acid will be further expanded, especially in the fields of complex disease management and veterinary medicine. However, its use also needs to consider the interaction with the active ingredient and the bioavailability of the final drug to ensure the best therapeutic effect.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Pamoic Acid market?

What factors are driving Pamoic Acid market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Pamoic Acid market opportunities vary by end market size?

How does Pamoic Acid break out by Type, by Application?

This report presents a comprehensive overview of the global Pamoic Acid market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• Purity ≥ 99%
• Purity < 99%

Segment by Specification

• Medical Grade
• Industrial Grade
• Research Grade

Segment by Dosage Form

• Solid Powder
• Particles
• Compound Excipients

Segment by Application

• Pharmaceutical Industry
• Chemical Industry
• Food Additives Industry
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Pamoic Acid market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Pharmaceutical Industry, Chemical Industry, Food Additives Industry evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact